Lucid Diagnostics (LUCD) Price & Analysis

Compare

553 Followers

LUCD Stock Chart & Stats

$1.25

>-$0.01(-1.09%)

At close: Jan 08 4:00 PM EST

$1.25

>-$0.01(-1.09%)

Day’s Range― - ―

52-Week Range$0.75 - $1.80

Previous CloseN/A

Volume130.18K

Average Volume (3M)623.79K

Market Cap

$144.57M

Enterprise Value$140.53M

Total Cash (Recent Filing)$47.33M

Total Debt (Recent Filing)$24.34M

Price to Earnings (P/E)―

Beta0.07

Next Earnings

Mar 30, 2026

EPS Estimate

-0.09

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.10

Shares Outstanding137,683,000

10 Day Avg. Volume578,963

30 Day Avg. Volume623,794

Financial Highlights & Ratios

PEG Ratio0.05

Price to Book (P/B)7.67

Price to Sales (P/S)9.52

P/FCF Ratio-0.92

Enterprise Value/Market Cap0.97

Enterprise Value/Revenue0.12

Enterprise Value/Gross Profit-0.29

Enterprise Value/Ebitda-0.01

Forecast

1Y Price Target

$4.05

Price Target Upside224.00% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering5

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Financial StabilityStable cash burn and a cash balance of approximately $47M provide financial stability for LUCD.

Market OpportunityThe estimated addressable domestic market opportunity for EsoGuard is ~$2 billion based on tens of millions of U.S. patients with gastroesophageal reflux disease (GERD).

Medicare CoverageThere is a high likelihood that Medicare issues a positive coverage determination for Esoguard.

Bears Say

Financial PerformanceLucid burned $10.9 million in free cash flow in 3Q25, which is higher than the analyst's estimate of $6.6 million.

Revenue ConcernsLUCD missed consensus revenue, which could concern investors about the company's financial performance.

Lucid Diagnostics News

Lucid Diagnostics price target raised to $8.25 from $8 at Ascendiant

Ascendiant analyst Edward Woo raised the firm’s price target on Lucid Diagnostics (LUCD) to $8.25 from $8 and...

1d ago

LUCD

Lucid Diagnostics’ esophageal precancer detection tools show efficacy in study

Lucid Diagnostics (LUCD), a subsidiary of PAVmed (PAVM), announced new data from the largest reported real-world experience of...

2d ago

LUCD

PAVM

Lucid Diagnostics files $175M mixed securities shelf

17:08 EST Lucid Diagnostics (LUCD) files $175M mixed securities shelf Published first on TheFly – the ultimate source...

6d ago

LUCD

Lucid Diagnostics reports Q3 EPS (10c), consensus (9c)

Reports Q3 revenue $1.2M, consensus $1.35M. Lucid had cash and cash equivalents of $47.3M as of September 30,...

29d ago

LUCD

Lucid Diagnostics: Buy Rating Backed by Strong Growth, Financial Stability, and Strategic Expansion

Analyst Anthony Vendetti from Maxim Group maintained a Buy rating on Lucid Diagnostics and keeping the price target...

28d ago

LUCD

Lucid Diagnostics: Positive Indicators and Medicare Reimbursement Potential Support Buy Rating

Canaccord Genuity analyst Kyle Mikson CFA has maintained their bullish stance on LUCD stock, giving a Buy rating...

28d ago

LUCD

Positive Outlook for Lucid Diagnostics: Buy Rating Affirmed Amid Growth in EsoGuard Test Volumes and Strong Financial Management

Analyst Michael Matson of Needham reiterated a Buy rating on Lucid Diagnostics, retaining the price target of $3.00....

28d ago

LUCD

Lucid Diagnostics Reports Q3 2025 Financial Results

Lucid Diagnostics Inc. ( ($LUCD) ) has released its Q3 earnings. Here is a breakdown of the information...

29d ago

LUCD

Lucid Diagnostics’ Earnings Call: Strategic Wins Amid Challenges

Lucid Diagnostics Inc. (($LUCD)) has held its Q3 earnings call. Read on for the main highlights of the...

29d ago

LUCD

Lucid Diagnostics Gains Medicare Support for EsoGuard

Lucid Diagnostics ( ($LUCD) ) has issued an update. Lucid Diagnostics reported its third-quarter 2025 financial results, highlighting...

29d ago

LUCD

Lucid Diagnostics Appoints John R. Palumbo to Board

The latest announcement is out from Lucid Diagnostics ( ($LUCD) ). On September 25, 2025, Lucid Diagnostics announced...

3M ago

LUCD

Lucid Diagnostics Completes Public Offering for $26.9 Million

Lucid Diagnostics ( ($LUCD) ) has shared an update. On September 11, 2025, Lucid Diagnostics Inc. announced the...

3M ago

LUCD

Lucid Diagnostics Announces Public Stock Offering

Lucid Diagnostics ( ($LUCD) ) has shared an announcement. On September 10, 2025, Lucid Diagnostics entered into an...

3M ago

LUCD

Morning Movers: Oracle powers market higher following ‘blowout’ Q1 results

Stock futures climbed to fresh record highs driven by Oracle’s pre-market performance. The cloud computing giant has soared...

3M ago

GME

AVAV

LUCD FAQ

What was Lucid Diagnostics Inc.’s price range in the past 12 months?

Lucid Diagnostics Inc. lowest stock price was $0.75 and its highest was $1.80 in the past 12 months.

What is Lucid Diagnostics Inc.’s market cap?

Lucid Diagnostics Inc.’s market cap is $144.57M.

When is Lucid Diagnostics Inc.’s upcoming earnings report date?

Lucid Diagnostics Inc.’s upcoming earnings report date is Mar 30, 2026 which is in 109 days.

How were Lucid Diagnostics Inc.’s earnings last quarter?

Lucid Diagnostics Inc. released its earnings results on Nov 12, 2025. The company reported -$0.1 earnings per share for the quarter, missing the consensus estimate of -$0.095 by -$0.005.

Is Lucid Diagnostics Inc. overvalued?

According to Wall Street analysts Lucid Diagnostics Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Lucid Diagnostics Inc. pay dividends?

Lucid Diagnostics Inc. does not currently pay dividends.

What is Lucid Diagnostics Inc.’s EPS estimate?

Lucid Diagnostics Inc.’s EPS estimate is -0.09.

How many shares outstanding does Lucid Diagnostics Inc. have?

Lucid Diagnostics Inc. has 137,683,000 shares outstanding.

What happened to Lucid Diagnostics Inc.’s price movement after its last earnings report?

Lucid Diagnostics Inc. reported an EPS of -$0.1 in its last earnings report, missing expectations of -$0.095. Following the earnings report the stock price went up 6.731%.

Which hedge fund is a major shareholder of Lucid Diagnostics Inc.?

Currently, no hedge funds are holding shares in LUCD

Lucid Diagnostics Stock Smart Score

Underperform

Fundamentals

Return on Equity

-331.24%

Trailing 12-Months

Asset Growth

135.41%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Lucid Diagnostics Inc.

Lucid Diagnostics (LUCD) is a medical diagnostics company focused on developing and commercializing innovative solutions for the early detection and prevention of gastrointestinal diseases, particularly esophageal cancer. The company operates primarily in the healthcare sector, leveraging its proprietary technology to provide non-invasive diagnostic tests that aid physicians in identifying precancerous conditions. Its core product, the EsoGuard test, is designed to analyze cells from the esophagus to detect early signs of cancer and other related disorders, facilitating timely intervention and improving patient outcomes.

Lucid Diagnostics (LUCD) Earnings & Revenues

Historic Earnings Reports

LUCD Company Deck

LUCD Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The call highlighted significant strategic achievements, including strengthening the market access team and positive progress towards Medicare coverage, which are expected to drive future growth. However, the company faced flat revenue growth and ongoing reimbursement challenges, impacting short-term financial performance.View all LUCD earnings summaries

LUCD Stock 12 Month Forecast

Average Price Target

$4.05

▲(224.00% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"$4","9":"$9","-1":"-$1","1.5":"$1.5","6.5":"$6.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":8.25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$8.25</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.05,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$4.05</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,1.5,4,6.5,9],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.01,1.5669230769230769,2.123846153846154,2.680769230769231,3.237692307692308,3.794615384615385,4.351538461538461,4.908461538461538,5.4653846153846155,6.022307692307693,6.57923076923077,7.136153846153847,7.693076923076923,{"y":8.25,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.01,1.2438461538461538,1.4776923076923076,1.7115384615384617,1.9453846153846155,2.1792307692307693,2.413076923076923,2.646923076923077,2.8807692307692307,3.1146153846153846,3.348461538461539,3.582307692307692,3.8161538461538465,{"y":4.05,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.01,1.1630769230769231,1.3161538461538462,1.4692307692307693,1.6223076923076922,1.7753846153846156,1.9284615384615384,2.081538461538462,2.2346153846153847,2.3876923076923076,2.540769230769231,2.6938461538461542,2.846923076923077,{"y":3,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.92,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.98,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.82,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.48,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.42,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.29,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.24,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.1,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.28,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.02,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.21,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.01,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >